Sanjiv Bhasin, a renowned finance expert, believes that while the Indian rupee is facing challenges, the pharmaceutical sector can be a good investment choice. Bhasin highlights the fact that the Indian rupee has depreciated significantly against the US dollar, making pharma stocks a profitable option. He goes on to provide two specific pharma stocks that he believes will perform well in the current market conditions. As investors are looking for ways to safeguard their investments amid the weak rupee, Bhasin’s recommendation can be a valuable insight. To know more about these stocks, read the full article.